Nervgen Pharma Corp.
NGEN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001751912
No open-market purchases or sales by Nervgen Pharma Corp. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $24.9M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Nervgen Pharma Corp. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 20.0K | +20.0K |
| Value | $0 | $25.0K | +$25.0K |
New holders (1)
Institutions that held Nervgen Pharma Corp. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 20,000 | $25.0K | 0.01% |
Sold out (0)
Institutions that held Nervgen Pharma Corp. at the end of Q1 2021 and filed for Q2 2021 without it.
None.